{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:08:21Z","timestamp":1792796901371,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7676","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/nature24058","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T12:17:44Z","timestamp":1507637864000},"page":"398-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Radically truncated MeCP2 rescues Rett syndrome-like neurological defects"],"prefix":"10.1038","volume":"550","author":[{"given":"Rebekah","family":"Tillotson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Selfridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha V.","family":"Koerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal K. E.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"De Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph D.","family":"Hector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"BFnature24058_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185\u2013188 (1999)","journal-title":"Nat. Genet."},{"key":"BFnature24058_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","volume":"69","author":"JD Lewis","year":"1992","unstructured":"Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905\u2013914 (1992)","journal-title":"Cell"},{"key":"BFnature24058_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","volume":"37","author":"PJ Skene","year":"2010","unstructured":"Skene, P. J. et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457\u2013468 (2010)","journal-title":"Mol. Cell"},{"key":"BFnature24058_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrg3897","volume":"16","author":"MJ Lyst","year":"2015","unstructured":"Lyst, M. J. & Bird, A. Rett syndrome: a complex disorder with simple roots. Nat. Rev. Genet. 16, 261\u2013275 (2015)","journal-title":"Nat. Rev. Genet."},{"key":"BFnature24058_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nn.3434","volume":"16","author":"MJ Lyst","year":"2013","unstructured":"Lyst, M. J. et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR\/SMRT co-repressor. Nat. Neurosci. 16, 898\u2013902 (2013)","journal-title":"Nat. Neurosci."},{"key":"BFnature24058_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224\u20131229 (2008)","journal-title":"Science"},{"key":"BFnature24058_CR7","doi-asserted-by":"publisher","first-page":"49479","DOI":"10.1074\/jbc.M409070200","volume":"279","author":"L Jeffery","year":"2004","unstructured":"Jeffery, L. & Nakielny, S. Components of the DNA methylation system of chromatin control are RNA-binding proteins. J. Biol. Chem. 279, 49479\u201349487 (2004)","journal-title":"J. Biol. Chem."},{"key":"BFnature24058_CR8","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1073\/pnas.0608056104","volume":"104","author":"X Nan","year":"2007","unstructured":"Nan, X. et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl Acad. Sci. USA 104, 2709\u20132714 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24058_CR9","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1093\/nar\/gkm599","volume":"35","author":"N Agarwal","year":"2007","unstructured":"Agarwal, N. et al. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res. 35, 5402\u20135408 (2007)","journal-title":"Nucleic Acids Res."},{"key":"BFnature24058_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.devcel.2014.01.032","volume":"28","author":"T-L Cheng","year":"2014","unstructured":"Cheng, T.-L. et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8\/Drosha complex. Dev. Cell 28, 547\u2013560 (2014)","journal-title":"Dev. Cell"},{"key":"BFnature24058_CR11","doi-asserted-by":"publisher","first-page":"17551","DOI":"10.1073\/pnas.0507856102","volume":"102","author":"JI Young","year":"2005","unstructured":"Young, J. I. et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA 102, 17551\u201317558 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24058_CR12","first-page":"420","volume":"15","author":"F Della Ragione","year":"2016","unstructured":"Della Ragione, F., Vacca, M., Fioriniello, S., Pepe, G. & D\u2019Esposito, M. MECP2, a multi-talented modulator of chromatin architecture. Brief. Funct. Genomics 15, 420\u2013431 (2016)","journal-title":"Brief. Funct. Genomics"},{"key":"BFnature24058_CR13","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1093\/nar\/21.21.4886","volume":"21","author":"X Nan","year":"1993","unstructured":"Nan, X., Meehan, R. R. & Bird, A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21, 4886\u20134892 (1993)","journal-title":"Nucleic Acids Res."},{"key":"BFnature24058_CR14","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/nar\/gkh349","volume":"32","author":"S Kriaucionis","year":"2004","unstructured":"Kriaucionis, S. & Bird, A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32, 1818\u20131823 (2004)","journal-title":"Nucleic Acids Res."},{"key":"BFnature24058_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/MCB.16.1.414","volume":"16","author":"X Nan","year":"1996","unstructured":"Nan, X., Tate, P., Li, E. & Bird, A. DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol. 16, 414\u2013421 (1996)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature24058_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/jmg.40.7.487","volume":"40","author":"S Kudo","year":"2003","unstructured":"Kudo, S. et al. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J. Med. Genet. 40, 487\u2013493 (2003)","journal-title":"J. Med. Genet."},{"key":"BFnature24058_CR17","doi-asserted-by":"publisher","first-page":"E3243","DOI":"10.1073\/pnas.1700731114","volume":"114","author":"V Kruusvee","year":"2017","unstructured":"Kruusvee, V. et al. Structure of the MeCP2\u2013TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders. Proc. Natl Acad. Sci. USA 114, E3243\u2013E3250 (2017)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24058_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143\u20131147 (2007)","journal-title":"Science"},{"key":"BFnature24058_CR19","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1093\/hmg\/dds208","volume":"21","author":"H Cheval","year":"2012","unstructured":"Cheval, H. et al. Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum. Mol. Genet. 21, 3806\u20133814 (2012)","journal-title":"Hum. Mol. Genet."},{"key":"BFnature24058_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/hmg\/ddv496","volume":"25","author":"K Brown","year":"2016","unstructured":"Brown, K. et al. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome. Hum. Mol. Genet. 25, 558\u2013570 (2016)","journal-title":"Hum. Mol. Genet."},{"key":"BFnature24058_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322\u2013326 (2001)","journal-title":"Nat. Genet."},{"key":"BFnature24058_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nn.2997","volume":"15","author":"D Goffin","year":"2011","unstructured":"Goffin, D. et al. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat. Neurosci. 15, 274\u2013283 (2011)","journal-title":"Nat. Neurosci."},{"key":"BFnature24058_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","volume":"35","author":"M Shahbazian","year":"2002","unstructured":"Shahbazian, M. et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243\u2013254 (2002)","journal-title":"Neuron"},{"key":"BFnature24058_CR24","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/hmg\/ddn062","volume":"17","author":"RC Samaco","year":"2008","unstructured":"Samaco, R. C. et al. A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet. 17, 1718\u20131727 (2008)","journal-title":"Hum. Mol. Genet."},{"key":"BFnature24058_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","volume":"5","author":"KKE Gadalla","year":"2017","unstructured":"Gadalla, K. K. E. et al. Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome. Mol. Ther. Methods Clin. Dev. 5, 180\u2013190 (2017)","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"BFnature24058_CR26","doi-asserted-by":"publisher","first-page":"e1006793","DOI":"10.1371\/journal.pgen.1006793","volume":"13","author":"S Lagger","year":"2017","unstructured":"Lagger, S. et al. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain. PLoS Genet. 13, e1006793 (2017)","journal-title":"PLoS Genet."},{"key":"BFnature24058_CR27","doi-asserted-by":"publisher","first-page":"15114","DOI":"10.1073\/pnas.1618737114","volume":"113","author":"B Kinde","year":"2016","unstructured":"Kinde, B., Wu, D. Y., Greenberg, M. E. & Gabel, H. W. DNA methylation in the gene body influences MeCP2-mediated gene repression. Proc. Natl Acad. Sci. USA 113, 15114\u201315119 (2016)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24058_CR28","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2013.01.038","volume":"152","author":"SA Baker","year":"2013","unstructured":"Baker, S. A. et al. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152, 984\u2013996 (2013)","journal-title":"Cell"},{"key":"BFnature24058_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","volume":"52","author":"Z Zhou","year":"2006","unstructured":"Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255\u2013269 (2006)","journal-title":"Neuron"},{"key":"BFnature24058_CR30","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nn.2866","volume":"14","author":"H Li","year":"2011","unstructured":"Li, H., Zhong, X., Chau, K. F., Williams, E. C. & Chang, Q. Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat. Neurosci. 14, 1001\u20131008 (2011)","journal-title":"Nat. Neurosci."},{"key":"BFnature24058_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/VCas systems. Science 339, 819\u2013823 (2013)","journal-title":"Science"},{"key":"BFnature24058_CR32","doi-asserted-by":"publisher","first-page":"16002","DOI":"10.1038\/mtm.2016.2","volume":"3","author":"N Cl\u00e9ment","year":"2016","unstructured":"Cl\u00e9ment, N. & Grieger, J. C. Manufacturing of recombinant adeno-associated viral vectors for clinical trials. Mol. Ther. Methods Clin. Dev. 3, 16002 (2016)","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"BFnature24058_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mt.2012.200","volume":"21","author":"KKE Gadalla","year":"2013","unstructured":"Gadalla, K. K. E. et al. Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol. Ther. 21, 18\u201330 (2013)","journal-title":"Mol. Ther."},{"key":"BFnature24058_CR34","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1073\/pnas.0811648106","volume":"106","author":"J Tao","year":"2009","unstructured":"Tao, J. et al. Phosphorylation of MeCP2 at serine 80 regulates its chromatin association and neurological function. Proc. Natl Acad. Sci. USA 106, 4882\u20134887 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24058_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature12348","volume":"499","author":"DH Ebert","year":"2013","unstructured":"Ebert, D. H. et al. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499, 341\u2013345 (2013)","journal-title":"Nature"},{"key":"BFnature24058_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.molcel.2007.12.028","volume":"29","author":"KL Ho","year":"2008","unstructured":"Ho, K. L. et al. MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol. Cell 29, 525\u2013531 (2008)","journal-title":"Mol. Cell"},{"key":"BFnature24058_CR37","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/1873-3468.12328","volume":"590","author":"MJ Lyst","year":"2016","unstructured":"Lyst, M. J., Connelly, J., Merusi, C. & Bird, A. Sequence-specific DNA binding by AT-hook motifs in MeCP2. FEBS Lett. 590, 2927\u20132933 (2016)","journal-title":"FEBS Lett."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature24058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature24058","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature24058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature24058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:05:58Z","timestamp":1684418758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature24058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":37,"journal-issue":{"issue":"7676","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFnature24058"],"URL":"https:\/\/doi.org\/10.1038\/nature24058","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731966459.793544049","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"29 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B. is a member of the Board of ArRETT, a company based in the USA with the goal of developing therapies for Rett syndrome.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}